Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal epithelial tight junction (TJ) complex is a highly specialized multi-protein structure located at the apical-most part of the lateral intercellular space between adjacent epithelial cells (StatPearls, 2023). It functions as a primary semi-permeable barrier, regulating the paracellular movement of ions, water, and solutes while restricting the passage of harmful pathogens and environmental antigens (PubMed, PMID: 21248165). The complex consists of transmembrane proteins, including claudins, occludin, and junctional adhesion molecules (JAMs), which interact with intracellular scaffold proteins like zonula occludens (ZO-1, ZO-2, ZO-3) to link the junction to the actin cytoskeleton (UniProt, P15151). Dysfunction or "leakiness" of this complex is a critical factor in the pathogenesis of various gastrointestinal and systemic disorders, such as Crohn's disease, celiac disease, and type 1 diabetes (PubMed, PMID: 22109896). Therapeutic interventions, such as larazotide acetate, aim to stabilize the TJ complex or inhibit the zonulin pathway to restore barrier integrity and reduce inflammation (ClinicalTrials.gov, NCT03573258). Monitoring the integrity of this complex is often achieved through biomarkers like serum zonulin levels or the lactulose/mannitol ratio (PubMed, PMID: 21248165).
Tight junction modulation, Zonulin antagonism, Regulation of claudin and occludin expression
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial tight junction complex (TJ complex) (TJ complex).